<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: It has been suggested that patients with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> have a substantially increased risk of esophageal and possibly extra-<z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancers</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>We compared the incidence of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> and the survival rates of patients with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> with those observed in patients with <z:hpo ids='HP_0002571'>achalasia</z:hpo>, with <z:e sem="disease" ids="C0267081" disease_type="Disease or Syndrome" abbrv="">Schatzki's ring</z:e>, and in the general population </plain></SENT>
<SENT sid="2" pm="."><plain>PATIENTS AND METHODS: From 1980 through 1994, 60 consecutive patients with newly diagnosed long-segment <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> without <z:mpath ids='MPATH_589'>dysplasia</z:mpath> were seen in a single gastroenterology consultation office and followed until the Fall of 1999 </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> incidence and survival rates were compared with age- and sex-matched patients with symptomatic <z:e sem="disease" ids="C0267081" disease_type="Disease or Syndrome" abbrv="">Schatzki's ring</z:e> (n = 60) and <z:hpo ids='HP_0002571'>achalasia</z:hpo> (n = 60) </plain></SENT>
<SENT sid="4" pm="."><plain>Survival data were also compared with those of the German population </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: During a mean (+/-SD) observation period of 10 +/- 5 years, 2 patients with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> (3%; 95% confidence interval [CI]: 0% to 11%) developed <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e>, and 9 (15%; 95% CI: 7% to 27%) developed extra-<z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancers</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>These data differed only slightly from those of patients with <z:e sem="disease" ids="C0267081" disease_type="Disease or Syndrome" abbrv="">Schatzki's ring</z:e> (<z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e>: n = 1, 2%; 95% CI: 0% to 9%; extra-<z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancers</z:e>: n = 9, 15%; 95% CI: 7%-27%) and <z:hpo ids='HP_0002571'>achalasia</z:hpo> (no <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancers</z:e>, extra-<z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancers</z:e>: n = 3, 5%; 95% CI: 1% to 4%) </plain></SENT>
<SENT sid="7" pm="."><plain>Estimated 10-year survival was similar in patients with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> (83%), patients with symptomatic <z:e sem="disease" ids="C0267081" disease_type="Disease or Syndrome" abbrv="">Schatzki's ring</z:e> (80%), patients with <z:hpo ids='HP_0002571'>achalasia</z:hpo> (87%), and in the general population (82%) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: The <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk in patients with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> has been overestimated </plain></SENT>
<SENT sid="9" pm="."><plain>If patients with nondysplastic epithelium are followed, the risk of <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e> is about 1 per 300 patient-years </plain></SENT>
</text></document>